Prestige Consumer Healthcare Inc
Prestige Consumer Healthcare Inc/ US74112D1019 /
PBH
18/06/2024 22:10:00
|
Chg.
+0.10
|
Volume |
Bid00:11:36 |
Demandez à00:11:36 |
Capitalisation boursière |
Dividende Y. |
Rapport P/E |
64.96USD
|
+0.15%
|
181,271 Chiffrre d'affaires: 6.1 Mio. |
59.50Bid taille: 100 |
67.94Ask la taille: 100 |
3.24 Mrd.USD |
- |
- |
Description de l'entreprise
Prestige Consumer Healthcare, Inc. markets and distributes brand name over-the-counter healthcare products throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s brands include Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® eye care products, DenTek® and The Doctor's® oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® sore throat treatments, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Efferdent® denture care products, Luden's® throat drops, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia.
Conseil d'administration & Conseil de surveillance
PDG |
Ron Lombardi |
Conseil d'administration |
Christine Sacco, Adel Mekhail, Jeff Thompson, Jeff Zerillo, Mary Beth Fritz, William P'Pool |
Conseil de surveillance |
Ron Lombardi, Christopher J. Coughlin, Dawn M. Zier, Dr. Celeste A. Clark, Dr. Gary E. Costley, James M. Jenness, John E. Byom, Natale S. Ricciardi, Sheila A. Hopkins |
Données de l'entreprise
Nom: |
Prestige Consumer Healthcare, Inc. |
Adresse: |
660 White Plains Road,Tarrytown, New York 10591, USA |
Téléphone: |
+1-914-524-6800 |
Fax: |
- |
Courriel: |
Irinquiries@prestigebrands.com
|
Internet: |
www.prestigebrandsinc.com/ |
Industrie: |
Consumer Goods |
Secteur: |
Cosmetics |
Sous-secteur: |
Cosmetics |
Fin de l'exercice financier: |
31/03 |
Flotte libre: |
69.88% |
IPO date: |
- |
Relations avec les investisseurs
Nom: |
Phil Terpolilli |
Téléphone IR: |
+1-914-524-6819 |
IR-Fax: |
- |
E-mail IR: |
-
|
Principaux actionnaires
Freefloat |
|
69.88% |
BlackRock, Inc. |
|
12.50% |
The Vanguard Group |
|
10.72% |
Dimensional Fund Advisors LP |
|
6.90% |